The START criteria most frequently giving rise to new PPOs at discharge, not observed at admission, were D2 “Fibre supplements for diverticulosis with a history of constipation” and C3 “Acetylcholinesterase inhibitor for mild-moderate Alzheimer’s dementia or Lewy Body dementia.” This evidence concerns the gene ACHE and Alzheimer disease.